Results

Total Results: 1,112 records

Showing results for "phase".

221. Topic 0556 CE of Treatments for Diabetic Peripheral Neuropathy NSD SJ clean (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0658-140831.pdf
     July 19, 2014 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase

222. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0261_07-16-2010.pdf
     January 01, 2010 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase

223. Topic 0487 De-escalate Aggressive Behavior in Psychiatric Pts NSD FINAL CC clean (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0576-150420.pdf
     December 10, 2014 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase

224. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_june_2012.pdf
     January 01, 2012 - inclusion are those interventions expected to be within 0–4 years of potential diffusion (e.g., in phase … Results The table below lists the 15 topics for which (1) preliminary phase III data for drugs or phase … In September 2011, the company announced plans for its phase III trial after releasing final 48-week … results from its phase II trial. … Intarcia presents positive ITCA 650 phase 2 study results for type 2 diabetes at EASD.

225. Research Protocol: Safety of Vaccines Used for Routine Immunization in the United States (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/safety-vaccines-protocol.pdf
     January 30, 2020 - or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 (152174) 15 ("clinical trial" or "clinical trial, phase … i" or "clinical trial, phase ii" or clinical trial, phase iii or clinical trial, phase iv or controlled … randomized controlled trial").pt. or double-blind method/ or clinical trials as topic/ or clinical trials, phase … i as topic/ or clinical trials, phase ii as topic/ or clinical trials, phase iii as topic/ or clinical … trials, phase iv as topic/ or controlled clinical trials as topic/ or randomized controlled trials

226. Therapies for Children with Autism Spectrum Disorders—Research Protocol Document | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/autism/research-protocol
     December 07, 2009 - we revised the key questions to clarify the emphasis on examining the correlation of early treatment phase … KQ3: Are there any identifiable changes early in the treatment phase that predict treatment outcomes … KQ4: What is the evidence that effects measured at the end of the treatment phase predict long term … criteria developed based on our understanding of the literature developed during the topic refinement phase … Weekly during the review phase of the study, the Project Coordinator will report the number of abstracts

227. Lysosomal-Storage-Diseases-Therapies Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/lysosomal-storage-diseases-therapies_research-protocol.pdf
     November 15, 2012 - report, randomized clinical trials, simple before-after studies, case During the Topic Refinement phase … There also were a number of prospective phase I and II clinical studies that complemented the RCTs … we made a decision to compile the RCTs in the evidence map, supplementing them with prospective phase … We also sought prospective phase I or II nonrandomized studies that included patient subgroups with … If higher-level studies (RCTs, prospective phase I and II) were not available, case series (single-arm

228. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism_research-protocol.pdf
     December 09, 2009 - revised the key questions to clarify the emphasis on examining the correlation of early treatment phase … KQ3: Are there any identifiable changes early in the treatment phase that predict treatment outcomes … KQ4: What is the evidence that effects measured at the end of the treatment phase predict long term … criteria developed based on our understanding of the literature developed during the topic refinement phase … Weekly during the review phase of the study, the Project Coordinator will report the number of abstracts

229. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/therapies-for-autism-spectrum-disorder-2-9-2010.pdf
     January 01, 2010 - revised the key questions to clarify the emphasis on examining the correlation of early treatment phase … KQ3: Are there any identifiable changes early in the treatment phase that predict treatment outcomes … KQ4: What is the evidence that effects measured at the end of the treatment phase predict long term … criteria developed based on our understanding of the literature developed during the topic refinement phase … Weekly during the review phase of the study, the Project Coordinator will report the number of abstracts

230. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_june_2012.pdf
     January 01, 2012 - inclusion are those interventions expected to be within 0–4 years of potential diffusion (e.g., in phase … Results The table below lists the nine topics for which (1) preliminary phase III data on drug topics … and phase II or phase III data on device or procedure topics were available; (2) information was compiled … This study is an extension of a phase III, clinical trial (CONQUER). … Qnexa phase 3 data published in obesity show 14.4% average weight loss in severely obese patients

231. Chronic-urinary-retention-protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research-protocol.pdf
     November 19, 2012 - During the Topic Refinement phase of this project, Key Informants suggested that a review focused on … Method/ (118498) 21 Single  Blind Method/ (17086) 22 clinical trial/  (476450) 23 clinical trial, phase … i.pt. (12809) 24 clinical trial, phase ii.pt. (20505) 25 clinical trial, phase iii.pt. (7571) 26 clinical … trial, phase iv.pt. (759) 27 controlled clinical trial.pt. (85694) 28 randomized controlled trial.pt

232. Enhanced Functionality for the Distributed Research Network Pilot (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-expansion_research.pdf
     April 01, 2012 - The enhancements described below will be incorporated into Phase 2 of our Distributed Research Network … We designated this activity as Phase 1.5, to distinguish it from the task order that ended in August … Our approach was based on lessons learned from Phase 1 of DRN and specifically on our findings that … In Phase 1, the prototype demonstrated how participating members can issue queries through a network … Document Scope This document describes the functional requirements and design for DRN phase 1.5.

233. Systematic Review on Acute Treatments for Episodic Migraine: Surveillance Report 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-1.pdf
     June 01, 2022 - Phase 2 randomized placebo-controlled study of lasmiditan for the acute treatment of migraine in Japanese … treatment of migraine: pooled efficacy, safety, and tolerability from the ACHIEVE I and ACHIEVE II phase … pain burden in patients with treatment- resistant migraine: effects of galcanezumab in the CONQUER Phase … Ubrogepant for the acute treatment of migraine: pooled efficacy from ACHIEVE I and ACHIEVE II phase … Evaluation of injection-site-related adverse events with galcanezumab: a post hoc analysis of phase

234. Defining the Benefits of Stakeholder Engagement in Systematic Reviews | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/stakeholder-engagement-benefits/white-paper
     March 18, 2014 - interviews with an eye towards articulating the benefits of engaging specific types of stakeholders at each phase

235. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0359_10-15-2010.pdf
     January 01, 2010 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase

236. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0356_09-22-2010.pdf
     January 01, 2010 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase

237. Topic 0590 Strategies to Treat and Manage Infantile Hemangioma NSD FINAL_SJ (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0715-140408.pdf
     April 08, 2014 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase

238. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0265_02-29-2008.pdf
     January 01, 2008 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase

239. Topic 0610 CE of Treatments for Uterine Fibroids NSD FINAL (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0745-141009.pdf
     September 03, 2014 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase

240. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0251_05-20-2010.pdf
     January 01, 2010 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase